tiprankstipranks
Altimmune (ALT)
NASDAQ:ALT
US Market
ALT
Altimmune
RESEARCH TOOLSreports
Want to see ALT full AI Analyst Report?

Altimmune (ALT) Ratios

3,678 Followers

Altimmune Ratios

ALT's free cash flow for Q1 2026 was $0.00. For the 2026 fiscal year, ALT's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 29.56 18.55 13.11 17.26 11.31
Quick Ratio
 29.56 18.55 13.11 17.26 11.31
Cash Ratio
 8.62 2.92 3.53 11.13 6.51
Solvency Ratio
 -1.76 -1.60 -6.00 -5.32 -3.89
Operating Cash Flow Ratio
 -6.35 -4.50 -7.63 -6.24 -3.67
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 283.03M$ 223.16M$ 121.46M$ 193.09M$ 171.18M
Leverage Ratios
Debt-to-Assets Ratio
 0.11 0.13 0.01 <0.01 <0.01
Debt-to-Equity Ratio
 0.13 0.16 0.01 <0.01 <0.01
Debt-to-Capital Ratio
 0.11 0.14 0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.11 0.13 0.00 0.00 0.00
Financial Leverage Ratio
 1.18 1.24 1.13 1.09 1.12
Debt Service Coverage Ratio
 -34.58 -52.78 -10.53K -2.51K -10.53K
Interest Coverage Ratio
 -35.86 -57.76 -11.46K -2.74K -10.97K
Debt to Market Cap
 0.14 0.11 0.00 0.00 0.00
Interest Debt Per Share
 0.31 0.42 0.02 0.01 0.02
Net Debt to EBITDA
 0.66 0.09 0.37 1.53 1.30
Profitability Margins
Gross Profit Margin
-41519.44%100.00%100.00%100.00%100.00%
EBIT Margin
-259827.78%-212531.71%-475250.00%-20753.99%124855.88%
EBITDA Margin
-259605.56%-212258.54%-474060.00%-20642.02%124130.88%
Operating Profit Margin
-269216.67%-230460.98%-515860.00%-22518.54%129029.41%
Pretax Profit Margin
-253002.78%-216521.95%-475295.00%-20762.21%124867.65%
Net Profit Margin
-253002.78%-214860.98%-475295.00%-20762.21%124577.94%
Continuous Operations Profit Margin
-253002.78%-214860.98%-475295.00%-20762.21%124577.94%
Net Income Per EBT
100.00%99.23%100.00%100.00%99.77%
EBT Per EBIT
93.98%93.95%92.14%92.20%96.77%
Return on Assets (ROA)
-27.14%-31.47%-68.24%-41.99%-40.94%
Return on Equity (ROE)
-42.57%-39.17%-76.97%-45.57%-45.72%
Return on Capital Employed (ROCE)
-29.88%-35.67%-80.08%-48.33%-46.21%
Return on Invested Capital (ROIC)
-29.86%-35.36%-79.91%-48.21%-45.99%
Return on Tangible Assets
-27.14%-31.47%-68.24%-41.99%-43.55%
Earnings Yield
-23.99%-27.70%-18.57%-14.77%-10.97%
Efficiency Ratios
Receivables Turnover
 0.02 0.02 <0.01 0.09 -0.03
Payables Turnover
 9.79 0.00 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.17 0.13 0.05 0.65 -0.06
Asset Turnover
 <0.01 <0.01 <0.01 <0.01 >-0.01
Working Capital Turnover Ratio
 <0.01 <0.01 <0.01 <0.01 >-0.01
Cash Conversion Cycle
 16.84K 15.46K 56.89K 4.16K -13.64K
Days of Sales Outstanding
 16.88K 15.46K 56.89K 4.16K -13.64K
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 37.27 0.00 0.00 0.00 0.00
Operating Cycle
 16.88K 15.46K 56.89K 4.16K -13.64K
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.58 -0.77 -1.12 -1.42 -1.33
Free Cash Flow Per Share
 -0.58 -0.77 -1.12 -1.42 -1.34
CapEx Per Share
 <0.01 <0.01 0.00 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -2.25K -6.14K 0.00 -1.61K -496.71
Capital Expenditure Coverage Ratio
 -2.25K -6.14K 0.00 -1.61K -496.71
Operating Cash Flow Coverage Ratio
 -2.01 -1.89 -47.50 -112.98 -55.68
Operating Cash Flow to Sales Ratio
 -2.00K -1.65K -3.99K -177.96 920.38
Free Cash Flow Yield
-26.74%-21.24%-15.60%-12.66%-8.12%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -3.70 -3.61 -5.39 -6.77 -9.11
Price-to-Sales (P/S) Ratio
 6.64K 7.76K 25.60K 1.41K -11.35K
Price-to-Book (P/B) Ratio
 1.19 1.41 4.14 3.09 4.17
Price-to-Free Cash Flow (P/FCF) Ratio
 -3.32 -4.71 -6.41 -7.90 -12.31
Price-to-Operating Cash Flow Ratio
 -4.69 -4.71 -6.41 -7.90 -12.33
Price-to-Earnings Growth (PEG) Ratio
 -0.11 0.14 0.28 0.82 0.40
Price-to-Fair Value
 1.19 1.41 4.14 3.09 4.17
Enterprise Value Multiple
 -1.90 -3.56 -5.03 -5.28 -7.84
Enterprise Value
 207.43M 309.98M 476.69M 464.58M 661.97M
EV to EBITDA
 -2.22 -3.56 -5.03 -5.28 -7.84
EV to Sales
 5.76K 7.56K 23.83K 1.09K -9.73K
EV to Free Cash Flow
 -2.88 -4.59 -5.97 -6.12 -10.56
EV to Operating Cash Flow
 -2.88 -4.59 -5.97 -6.13 -10.58
Tangible Book Value Per Share
 2.28 2.55 1.74 3.65 3.68
Shareholders’ Equity Per Share
 2.28 2.55 1.74 3.65 3.95
Tax and Other Ratios
Effective Tax Rate
 0.00 <0.01 0.00 0.00 <0.01
Revenue Per Share
 <0.01 <0.01 <0.01 <0.01 >-0.01
Net Income Per Share
 -0.73 -1.00 -1.34 -1.66 -1.81
Tax Burden
 1.00 0.99 1.00 1.00 1.00
Interest Burden
 0.97 1.02 1.00 1.00 1.00
Research & Development to Revenue
 1.85K 1.62K 4.11K 154.46 -1.04K
SG&A to Revenue
 837.69 685.32 1.05K 42.58 -251.97
Stock-Based Compensation to Revenue
 235.97 392.10 719.65 24.98 -119.13
Income Quality
 0.79 0.77 0.84 0.86 0.74
Currency in USD